Use this URL to cite or link to this record in EThOS:
Title: Synthesis of novel Riluzole analogues
Author: Powell, Lucy Alice
ISNI:       0000 0004 5348 4061
Awarding Body: University of Huddersfield
Current Institution: University of Huddersfield
Date of Award: 2015
Availability of Full Text:
Access from EThOS:
Access from Institution:
Amyotrophic lateral sclerosis (ALS) is a progressive motor neuron disease that is universally fatal. The only drug that is currently FDA approved for the treatment of ALS is Riluzole (Figure 1), which improves life expectancy by a few months via an unknown mechanism. This thesis describes the preparation of novel Riluzole analogues with the overall aim of improving neuroprotective activity against ALS. Two libraries are reported based respectively on the incorporation of tetrahydropyridine and 1,4-substituted-1,2,3-triazole functionality to the benzothiazole ring. Both of these functional groups have been reported in pharmaceutically active drugs either already on the market or in late clinical trials related to the treatment towards motor neuron diseases. Tetrahydropyridine analogues were synthesised in a five step process by the generation of a diamine intermediate, followed by reaction with Zincke salt, cyclisation and reduction (Scheme 1). 1,4-Substituted-1,2,3-triazole analogues were synthesised by reaction of a terminal alkyne with an azide Riluzole analogue with substoichiometric amounts of CuI (Scheme 2). The azide analogue was generated by carrying out a diazotransfer reaction on the diamine intermediate followed by cyclisation with KSCN and Br2.
Supervisor: Sweeney, Joe Sponsor: Not available
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID:  DOI: Not available
Keywords: QD Chemistry